These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 28926632

  • 1. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    Ly HJ, Lokugamage N, Nishiyama S, Ikegami T.
    PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
    Nishiyama S, Slack OA, Lokugamage N, Hill TE, Juelich TL, Zhang L, Smith JK, Perez D, Gong B, Freiberg AN, Ikegami T.
    Virulence; 2016 Nov 16; 7(8):871-881. PubMed ID: 27248570
    [Abstract] [Full Text] [Related]

  • 6. Rift Valley Fever Phlebovirus Reassortment Study in Sheep.
    Balaraman V, Indran SV, Kim IJ, Trujillo JD, Meekins DA, Shivanna V, Zajac MD, Urbaniak K, Morozov I, Sunwoo SY, Faburay B, Osterrieder K, Gaudreault NN, Wilson WC, Richt JA.
    Viruses; 2024 May 30; 16(6):. PubMed ID: 38932172
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.
    Tercero B, Narayanan K, Terasaki K, Makino S.
    J Virol; 2021 Jun 24; 95(14):e0042921. PubMed ID: 33952635
    [Abstract] [Full Text] [Related]

  • 14. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.
    Ikegami T, Won S, Peters CJ, Makino S.
    J Virol; 2006 Mar 24; 80(6):2933-40. PubMed ID: 16501102
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM, Nfon CK, Zhang S, Marszal P, Wilson WC, Morrill JC, Bettinger GE, Peters CJ.
    Vaccine; 2014 Apr 25; 32(20):2345-9. PubMed ID: 24462482
    [Abstract] [Full Text] [Related]

  • 19. Development of monoclonal antibodies to Rift Valley Fever Virus and their application in antigen detection and indirect immunofluorescence.
    Mroz C, Schmidt KM, Reiche S, Groschup MH, Eiden M.
    J Immunol Methods; 2018 Sep 25; 460():36-44. PubMed ID: 29894749
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of two next-generation Rift Valley fever vaccines.
    Kortekaas J, Oreshkova N, van Keulen L, Kant J, Bosch BJ, Bouloy M, Moulin V, Goovaerts D, Moormann RJ.
    Vaccine; 2014 Sep 03; 32(39):4901-8. PubMed ID: 25050973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.